0000899243-17-023631.txt : 20171004
0000899243-17-023631.hdr.sgml : 20171004
20171004201715
ACCESSION NUMBER: 0000899243-17-023631
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170929
FILED AS OF DATE: 20171004
DATE AS OF CHANGE: 20171004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harford Simon N.R.
CENTRAL INDEX KEY: 0001443705
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21244
FILM NUMBER: 171123082
MAIL ADDRESS:
STREET 1: AVON PRODUCTS, INC.
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAREXEL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0000799729
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 042776269
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 195 WEST ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 7814879900
MAIL ADDRESS:
STREET 1: 195 WEST ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-29
1
0000799729
PAREXEL INTERNATIONAL CORP
PRXL
0001443705
Harford Simon N.R.
C/O PAREXEL INTERNATIONAL CORPORATION
195 WEST STREET
WALTHAM
MA
024514
0
1
0
0
See Remarks
Common Stock
2017-09-29
4
D
0
10736
D
0
D
Stock Options (Right to Buy)
73.97
2017-09-29
4
U
0
44028
14.13
D
2025-05-09
Common Stock
44028
0
D
Disposed of pursuant to the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017 (the "Merger Agreement"), whereby, at the effective time of the merger contemplated therein (the "Effective Time"), all issued and outstanding shares of the Issuer's common stock were automatically cancelled and converted into the right to receive $88.10 per share in cash without interest (the "Merger Consideration").
Pursuant to the terms of the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017, each Company Stock Option, whether or not vested or exercisable, automatically converted into the right to receive an amount in cash equal to the product obtained by multiplying (i) the excess of the Merger Consideration over the per share exercise price of such Company Stock Option, by (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of settlement of such Company Stock Option prior to the Effective Time.
Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 05/09/2013.
SVP and Chief Financial Officer
/s/ Douglas Batt, the Attorney-in-Fact for Simon Harford
2017-10-04